Pharmacology of Therapeutic Oligonucleotides

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 1997 English Publisher:Mary Ann Liebert IncJournal:Antisense and Nucleic Acid Drug Development, volume 7, pages 239-243 (issn: 1087-2906,

Copyright policy )

Authors: R B, Diasio; R, Zhang;

doi: 10.1089/oli.1.1997.7.239

pmid: 9212918

Pharmacology of Therapeutic Oligonucleotides

- Summary
- Subjects
- Metrics

Related Organizations

University of Alabama at Birmingham
United States
Alabama Agricultural and Mechanical University
United States

Keywords

Clinical Trials as Topic, Drug Evaluation, Preclinical, Biological Transport, Oligonucleotides, Antisense, Thionucleotides, Rats, Mice, Structure-Activity Relationship, Drug Design, Animals, Humans, RNA, Messenger, Protein Binding

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	14
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%